Abrdn PLC Edgewise Therapeutics, Inc. Transaction History
Abrdn PLC
- $50.5 Billion
- Q1 2025
A detailed history of Abrdn PLC transactions in Edgewise Therapeutics, Inc. stock. As of the latest transaction made, Abrdn PLC holds 313,025 shares of EWTX stock, worth $4.48 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
313,025
Previous 178,043
75.81%
Holding current value
$4.48 Million
Previous $4.75 Million
44.88%
% of portfolio
0.01%
Previous 0.01%
Shares
4 transactions
Others Institutions Holding EWTX
# of Institutions
222Shares Held
105MCall Options Held
2.57MPut Options Held
1.58M-
Orbimed Advisors LLC San Diego, CA15MShares$215 Million10.3% of portfolio
-
Ra Capital Management, L.P. Boston, MA8.91MShares$128 Million4.07% of portfolio
-
Perceptive Advisors LLC New York, NY6.55MShares$93.8 Million6.03% of portfolio
-
Baker Bros. Advisors LP New York, NY6.16MShares$88.2 Million1.61% of portfolio
-
Black Rock Inc. New York, NY6.02MShares$86.1 Million0.0% of portfolio
About Edgewise Therapeutics, Inc.
- Ticker EWTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 63,171,700
- Market Cap $905M
- Description
- Edgewise Therapeutics, Inc., a biopharmaceutical company, develops small molecule therapies for musculoskeletal diseases. The Company's lead product candidate, EDG-5506, is an orally administered small molecule designed to address the root cause of dystrophinopathies including Duchenne muscular dystrophy and Becker muscular dystrophy which has c...